Evidence map›Paper›PMID 15242528›Full record

ArticleHuman gene therapy2004

Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression.

Sunetra Ray, Ramasamy Paulmurugan, Isabel Hildebrandt, Meera Iyer, Lily Wu, Michael Carey, Sanjiv S Gambhir

Abstract readValidation Study
In one paragraph

Article in Human gene therapy, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular-genetic imaging of cancer.Advances in cancer research · 2014
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. A novel estrogen receptor intramolecular folding-based titratable transgene expression system.Molecular therapy : the journal of the American Society of Gene Therapy · 2009
    Article
  9. A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Article
  10. Noninvasive imaging of therapeutic gene expression using a bidirectional transcriptional amplification strategy.Molecular therapy : the journal of the American Society of Gene Therapy · 2008
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Gene therapy imaging in patients for oncological applications.European journal of nuclear medicine and molecular imaging · 2005
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sunetra RayCrump Institute for Molecular Imaging, and Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, CA 90095, USA.
Ramasamy Paulmurugan
Isabel Hildebrandt
Meera Iyer
Lily Wu
Michael Carey
Sanjiv S Gambhir
Institute for Molecular Medicine · US

Funding

Stanford Nanocharacterization LaboratoryU54CA119367 · NCI · STANFORD UNIVERSITY · PI AGUS, DAVID B · 2006 to 2010
$19.8M
Small Animal ImagingP50CA114747 · NCI · STANFORD UNIVERSITY · PI RAO, JIANGHONG · 2005 to 2014
$18.2M
Reporter Imaging of Protein-Protein InteractionsR01CA082214 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GAMBHIR, SANJIV S · 1999 to 2019
$5.9M
UCLA Imaging Resource for Mouse Cancer ModelsR24CA092865 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PHELPS, MICHAEL E · 2001 to 2006
$4.3M
NCI NIH HHS P50 CA114747NCI NIH HHS R01 CA082214NCI NIH HHS R01 CA82214NCI NIH HHS R24 CA092865NCI NIH HHS R24 CA92865NCI NIH HHS U54 CA119367
6 · The paper itself

Abstract

Molecular imaging methods have previously been employed to image tissue-specific reporter gene expression by a two-step transcriptional amplification (TSTA) strategy. We have now developed a new bidirectional vector system, based on the TSTA strategy, that can simultaneously amplify expression for both a target gene and a reporter gene, using a relatively weak promoter. We used the synthetic Renilla luciferase (hrl) and firefly luciferase (fl) reporter genes to validate the system in cell cultures and in living mice. When mammalian cells were transiently cotransfected with the GAL4-responsive bidirectional reporter vector and various doses of the activator plasmid encoding the GAL4-VP16 fusion protein, pSV40-GAL4-VP16, a high correlation (r(2) = 0.95) was observed between the expression levels of both reporter genes. Good correlations (r(2) = 0.82 and 0.66, respectively) were also observed in vivo when the transiently transfected cells were implanted subcutaneously in mice or when the two plasmids were delivered by hydrodynamic injection and imaged. This work establishes a novel bidirectional vector approach utilizing the TSTA strategy for both target and reporter gene amplification. This validated approach should prove useful for the development of novel gene therapy vectors, as well as for transgenic models, allowing noninvasive imaging for indirect monitoring and amplification of target gene expression.

Indexed as

AnimalsGene ExpressionGenes, ReporterGenetic TherapyGenetic VectorsHumansLuciferases, FireflyLuciferases, RenillaMaleMicePromoter Regions, GeneticTrans-ActivatorsGal-VP16Luciferases, FireflyLuciferases, RenillaTrans-Activators

Identifiers

PMID15242528
PMCPMC4153396
OpenAlexW2063832876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.